Informations techniques
Exploitant
OMNIVISION GmbH
Présentation
BRIMONIDINE OMNIVISION 2 mg/ml, collyre en solution en récipients unidoses - 60 récipients unidoses de 0,35 ml (CIP : 34009 301 500 3 0)
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
m6kFa7q9LH2A7rzW
